Blog

Elias Chandran: Our meta-analysis of dMMR and MSI-H in UC

Photo from Elias Chandran/X

May 5, 2024, 07:19

Elias Chandran: Our meta-analysis of dMMR and MSI-H in UC

Elias Chandran, Medical Oncologist at National Cancer Institute shared on X:

“Excited to share our meta-analysis of Mismatch repair deficiency (dMMR) and microsatellite instability-high (MSI-H) in Urothelial Carcinoma (UC)! These occur more in Upper Tract Urothelial Carcinoma (UTUC) than bladder cancer. And similar to rectal cancer, occur more in localized stage, and may predict ICB sensitivity and chemoresistance.”

Further Reading.
Source: Elias Chandran/X

cancer dMMR Elias Chandran microsatellite instability-high Mismatch repair deficiency MSI-H OncoDaily Oncology rectal cancer upper tract urothelial carcinoma urothelial carcinoma UTUC

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage